Brief: Lipigon Announces Preliminary Outcome Of The Rights Issue
22/05/2025 09:57
May 22 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST: SAID ON WEDNESDAY LIPIGON ANNOUNCES PRELIMINARY OUTCOME OF THE RIGHTS ISSUE 415,325,442 SHARES WERE SUBSCRIBED FOR, CORRESPONDING TO 100 PERCENT OF THE RIGHTS ISSUE Source text for Workspace: nBQNblxTrN Further company coverage: LPGO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds